Repros Therapeutics, Inc. (RPRX)

[Dr Bill]

A few requests in private, along with the posts here, lead me to say that I hear things through the grapevine, yet don't want to be skewered when they turn out to be outright fabrications (told to me, I don't make stuff up out of the blue), exaggerations, pie in the sky wishful thinking, etc.

BUT for those who are thinking that bioneophyte has a point, the offering must have been widely oversub'd because of the huge premium they got on the price compared to trading before and obviously after. They were able to get larger investors to pony up for the larger positions that were sought after by both parties.

However I would rather not speculate/detail what I'm hearing per se, but suffice to say that the December PR where Joe announced (paraphrase) "with these results in hand we're now going to seek a buyer/partner for androxal" is probably more close to realization, (sooner rather than later) than most would think. I wouldn't quite go "imminent" yet, and that a worldwide partnership would not surprise me. They could likely get 50/50/20 for that part of their program alone, which would catapult the enterprise value alone to above $20. Why worldwide rather than just euro and wait? I think they want to sell the company by this time next year....getting another 50 Million in the bank, and 50 to come with milestones and a promise to the buyer of another 20% of revs androxal worldwide plus the entire Proellex program, I still think this one's worth north of 80.